Atrion Corporation Inc. (ATRI): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Atrion Corp (ATRI)

Atrion Corporation possesses significant pricing power due to the integration of its patented valves into partner systems. Expansion into US clinics is driving market share growth for precision instruments. The company's P/S ratio on GURU.Markets reflects valuation dynamics, where the value 4.40 characterizes this level. Efficiency is maintained by outsourcing component assembly to contract manufacturers and utilizing global logistics outsourcing.

Price-to-Revenue Ratio: Atrion (ATRI) for 07/04/2022 - 08/31/2024

Metric breakdowns and analytics for Atrion Corp (ATRI)

- stock quotes and analyst forecast:
Price atrioncorp.com|ATRI - Price Target Chart
- stock exchange capitalization data:
Market Value Atrion Corp|ATRI - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share Atrion|ATRI - Company Book Value|Market Cap to Net Assets Ratio atrioncorp.com|ATRI - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Atrion Corporation|ATRI - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Atrion Corporation Inc.|ATRI - Company Total Debt|Debt to Book Capital Atrion Corp|ATRI - Company Long-Term Debt|Short-Term Debt Volume Atrion|Quick Ratio atrioncorp.com
- company profitability and valuation multiples indicators:
ATRI - Net Income|Future Net Profit Atrion Corporation|ATRI - Price to Earnings Ratio|Future Price to Earnings Multiple Atrion Corp.|ATRI - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Atrion Corp|ATRI - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Atrion|ATRI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months atrioncorp.com|ATRI - Net earnings per share growth this year|Expected earnings per share trend next year Atrion Corporation
- total revenue and sales volume data:
ATRI - Revenue and Sales Volume|Company Future Sales Volume atrioncorp.com|ATRI - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Atrion Corp
Summary company analytics:atrioncorp.com
Mass-produced product of atrioncorp.com

The P/S multiple determines the market value of a business relative to its generated sales volume, allowing an investor to assess whether an asset is overvalued or to identify potential undervaluation. The stability of the biomedical sector and the neutrality of Atrion Corporation (ATRI) minimize revenue volatility, making the company's P/S value a reliable indicator of fundamental resilience and capital protection against geopolitical shocks.

Competitors of Atrion Corporation

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAA: P/S Multiple|Niagen (NAGE) - P/S Multiple|Market Cap to Revenue ZIMV|ANGO (angiodynamics.com) - Market Cap to Sales Volume|Price-to-Revenue Ratio Cerus (CERS)|TKNO (Alpha Teknova) - Market Capitalization-to-Revenue Ratio|P/S Multiple MGRM (Monogram Technologies Inc)|Price-to-Revenue Coefficient Sharps Technology Inc (STSS)|INFU - Price-to-Revenue Ratio|Price to Sales utahmed.com|korumedical.com (KRMD) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio NYXH|Market Cap to Revenue MBOT|PDEX: Market Capitalization-to-Revenue Ratio|P/S Multiple ZTEK|Market Cap to Revenue elutia.com ELUT|Price-to-Revenue Ratio Milestone Scientific Inc. MLSS|NEXGEL Inc. (NXGL) - Price to Sales|RVP - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio HBIO (harvardbioscience.com)|Femasys Inc. (FEMY) - Price-to-Revenue Ratio|Price-to-Sales Ratio MHUA (Meihua Medical Technologies Co., Ltd.)|Price-to-Revenue Ratio Predictive Oncology Inc|Price to Sales Callan JMB Corp CJMB|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)